Related Experiment Videos
Hb Geelong [beta 139(H17)Asn----Asp]
P F Como1, D R Hocking, G W Swinton
1Haematology Department, Royal Prince Alfred Hospital, Camperdown, N.S.W., Australia.
Hemoglobin
|January 1, 1991
Summary
Hemoglobin Geelong, an unstable variant, was identified in a patient with beta-thalassemia. This hemoglobinopathy may worsen the thalassemia phenotype, impacting red blood cell oxygen transport.
Area of Science:
- Biochemistry
- Genetics
- Hematology
Background:
- Hemoglobinopathies are genetic disorders affecting hemoglobin structure or synthesis.
- Beta-thalassemia is characterized by reduced or absent beta-globin chain production.
- Unstable hemoglobin variants can lead to hemolytic anemia and other clinical manifestations.
Observation:
- A novel unstable hemoglobin variant, Hb Geelong [beta 139(H17)Asn----Asp], was identified in a German woman of Polish-Russian descent.
- The variant exhibited similar electrophoretic properties to normal adult hemoglobin (Hb A) under various conditions.
- Amino acid analysis and dansyl-Edman degradation confirmed the Asn to Asp substitution at the beta 139 position.
Findings:
- Hb Geelong appears to exacerbate the phenotype of beta-thalassemia, increasing disease severity.
- The observed increase in blood P50 was attributed to elevated 2,3-diphosphoglycerate levels in response to anemia, not the substitution itself.
- Impaired synthesis of the variant beta-globin chain contributes to the low concentration of Hb Geelong in peripheral blood.
Implications:
- This finding expands the known spectrum of hemoglobin variants associated with beta-thalassemia.
- Understanding the molecular basis of Hb Geelong provides insights into hemoglobin instability and its clinical consequences.
- Further family studies are needed to elucidate the inheritance patterns of Hb Geelong and beta-thalassemia in this patient.